Advanced MR Techniques for Preoperative Glioma Characterization: Part 1

Autoři	HIRSCHLER Lydiane SOLLMANN Nico SCHMITZ-ABECASSIS Barbara PINTO Joana ARZANFOROOSH Fatemehsadat BARKHOF Frederik BOOTH Thomas CALVO-IMIRIZALDU Marta CASSIA Guilherme CHMELIK Marek CLEMENT Patricia ERCAN Ece FERNANDEZ-SEARA Maria A FURTNER Julia FUSTER-GARCIA Elies GRECH-SOLLARS Matthew GUVEN Nazmiye Tugay HATAY Gokce Hale KARAMI Golestan KEIL Vera C KIM Mina KOEKKOEK Johan A F KUKRAN Simran MANCINI Laura NECHIFOR Ruben Emanuel OEZCAN Alpay OZTURK-ISIK Esin PISKIN Senol SCHMAINDA Kathleen SVENSSON Siri F TSENG Chih-Hsien UNNIKRISHNAN Saritha VOS Frans WARNERT Esther ZHAO Moss Y JANČÁLEK Radim NUNES Teresa EMBLEM Kyrre E SMITS Marion PETR Jan HANGEL Gilbert
Rok publikování	2023
Druh	Článek v odborném periodiku
Časopis / Zdroj	Journal of Magnetic Resonance Imaging
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
www	https://onlinelibrary.wiley.com/doi/10.1002/jmri.28662
Doi	http://dx.doi.org/10.1002/jmri.28662
Klíčová slova	glioma; brain; preoperative; contrasts; GliMR 2; 0; level of clinical validation
Popis	Preoperative clinical magnetic resonance imaging (MRI) protocols for gliomas, brain tumors with dismal outcomes due to their infiltrative properties, still rely on conventional structural MRI, which does not deliver information on tumor genotype and is limited in the delineation of diffuse gliomas. The GliMR COST action wants to raise awareness about the state of the art of advanced MRI techniques in gliomas and their possible clinical translation or lack thereof. This review describes current methods, limits, and applications of advanced MRI for the preoperative assessment of glioma, summarizing the level of clinical validation of different techniques. In this first part, we discuss dynamic susceptibility contrast and dynamic contrast-enhanced MRI, arterial spin labeling, diffusion-weighted MRI, vessel imaging, and magnetic resonance fingerprinting. The second part of this review addresses magnetic resonance spectroscopy, chemical exchange saturation transfer, susceptibility-weighted imaging, MRI-PET, MR elastography, and MR-based radiomics applications.Evidence Level: 3Technical Efficacy: Stage 2